PharmaShots | Incisive News in 3 Shots

Subscribe Now

Anheart Therapeutics

The NMPA Accepts Anheart Therapeutics & Innovent’s NDA for Taletrectinib and Grants Priority Review for the Treatment of Non-Small Cell Lung Cancer

The NMPA Accepts Anheart Therapeutics & Innovent’s NDA for Taletrectinib and Grants Priority Review for the Treatment of Non-Small...

December 19, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us